Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies

Published:2018-07-30 Issue:10 Volume:7 Page:e1494113
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Wang Peng-Fei¹,Song Si-Ying²,Wang Ting-Jian¹,Ji Wen-Jun³,Li Shou-Wei¹,Liu Ning¹,Yan Chang-Xiang¹

Affiliation:

1. Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China

2. School of Basic Medical Sciences, Capital Medical University, Beijing, China

3. Department of Neurosurgery, Key Laboratory, The Second Hospital of Yulin, Xi’an Jiao tong University, Xi’an, China

Funder

National Key Technology Research and Development Program of the Ministry of Science and Technology of China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1494113

Reference95 articles.

1. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

2. Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells

3. Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients

4. Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-10 overexpression in 4T1 cells: A gateway to suppressing mammary carcinoma growth;International Immunopharmacology;2024-12

2. Systemically targeting monocytic myeloid-derived suppressor cells using dendrimers and their cell-level biodistribution kinetics;Journal of Controlled Release;2024-10

3. CD300ld: A new target for tumor immunotherapy and new hope for cancer patients;Science Bulletin;2024-09

4. Myeloid-Derived Suppressor Cells and Macrophage Polarization in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

5. Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis;Cancers;2024-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3